scPharmaceuticals - Bathi saben saham sajroning taun lumaku SCPH

scPharmaceuticals Inc. (SCPH) automates drug delivery via sc2Wear intelligent wearable pumps, utilizing AI to manage infusion. The business focuses on developing home treatment systems for heart failure, eliminating the need for inpatient IV drips. The EPS TTM price action is -6.80. Stable cash flow is driven by recognition from the medical community, confirming the high relevance and financial sustainability of the offered solutions.
scPharmaceuticals - rincian analitis lan metrik utama (SCPH)

Year-over-year (TTM) EPS growth reflects the dynamics of net income per share over the last twelve months relative to the same period last year. This calculation eliminates seasonality from the financial result, measuring the actual efficiency of capital generation. By analyzing this YoY TTM earnings per share chart, an investor can discern the pace of business scaling. For scPharmaceuticals Inc. (SCPH), this metric remains volatile due to the initial stage of introducing infusion systems to the market.